Adenocarcinoma of the Pancreas
Oncology
Prevalence
0.1 / 100K
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| onivyde | MERRIMACK PHARMACEUTICALS INC (MACK) |
Compare drugs
Frequently asked questions
How many drugs are in development for Adenocarcinoma of the Pancreas?
BioSniper tracks 3 drugs in development for Adenocarcinoma of the Pancreas across 2 companies.
How many clinical trials target Adenocarcinoma of the Pancreas?
There are 1 clinical trial targeting Adenocarcinoma of the Pancreas tracked by BioSniper.
What is the prevalence of Adenocarcinoma of the Pancreas?
The estimated prevalence of Adenocarcinoma of the Pancreas is approximately 0.1 per 100,000 population.
Deep-dive into Adenocarcinoma of the Pancreas
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis